Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Prepaid Assets (2023 - 2025)

Historic Prepaid Assets for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $8.8 million.

  • Tonix Pharmaceuticals Holding's Prepaid Assets fell 1504.92% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year decrease of 1504.92%. This contributed to the annual value of $8.1 million for FY2024, which is 1139.31% down from last year.
  • Per Tonix Pharmaceuticals Holding's latest filing, its Prepaid Assets stood at $8.8 million for Q3 2025, which was down 1504.92% from $9.9 million recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's 5-year Prepaid Assets high stood at $12.0 million for Q2 2023, and its period low was $6.4 million during Q1 2025.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's median Prepaid Assets value was $9.5 million (recorded in 2023), while the average stood at $9.6 million.
  • The largest annual percentage gain for Tonix Pharmaceuticals Holding's Prepaid Assets in the last 5 years was 1875.22% (2025), contrasted with its biggest fall of 4009.16% (2025).
  • Tonix Pharmaceuticals Holding's Prepaid Assets (Quarter) stood at $9.2 million in 2023, then dropped by 11.39% to $8.1 million in 2024, then grew by 8.25% to $8.8 million in 2025.
  • Its Prepaid Assets was $8.8 million in Q3 2025, compared to $9.9 million in Q2 2025 and $6.4 million in Q1 2025.